相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human VEGFR2.
- 亚型:
IgG
- 形态:
液体
- 保存条件:
Store at 4°C. Product is guaranteed 6 months from the date of shipment.
- 克隆性:
多克隆
- 标记物:
FITC-conjugated
- 适应物种:
H、M、R
- 保质期:
1-2年
- 抗原来源:
human VEGFR2
- 目录编号:
Accession No.
- 级别:
超纯
- 库存:
一定量库存
- 供应商:
ABBIOTEC
- 宿主:
Rabbit
- 应用范围:
IHC、IF
- 浓度:
0.1 ml
- 靶点:
VEGFR2
- 抗体英文名:
VEGFR2 Antibody
- 抗体名:
FITC-conjugated-VEGFR2 Antibody
- 规格:
0.1 ml
FITC-conjugated-VEGFR2 Antibody产品详细介绍:
| 产品名称: | FITC-conjugated-VEGFR2 Antibody |
| 说明书: | 【点击查看详细说明及参考图片】 |
| 货号: | 254016 |
| 规格: | 0.1 ml |
| 产品描述: | VEGFR-2 (Vascular endothelial growth factor receptor 2) is a tyrosine-protein kinase and receptor for VEGF or VEGFC. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In HIV-1 infection cases, VEGFR2 interaction with extracellular viral Tat protein enhances angiogenesis in Kaposi's sarcoma lesions. |
| 克隆类型: | Rabbit Polyclonal Antibody |
| 免疫原: | KLH-conjugated synthetic peptide encompassing a sequence within the C-term region of human VEGFR2. |
| 适用物种: | H, M, R |
| 应用范围: | IF, IHC |
| 应用说明: | IF: 1:20-1:100; IHC: 1:50-1:200 |
| 别名: | Vascular endothelial growth factor receptor 2; VEGFR-2; Protein-tyrosine kinase receptor Flk-1; Kinase insert domain receptor; CD309; KDR; FLK1 |
| 形态: | Each vial contains 0.1 mg IgG in 0.1 ml (1 mg/ml) of PBS pH7.4, 1 mg/ml BSA, 25% glycerol with 0.09% sodium azide. Antibody was purified by Protein-A affinity chromatography. |
| 保存条件: | Store at 4°C. Product is guaranteed 6 months from the date of shipment. |
| 参考文献: |
ABBIOTEC产品提供质量保证,提供完善的售后和技术支持,ABBIOTEC产品正品包装:
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验of conjugated-Ig is added to the column. If 2mL of conjugated-Ig is added, discard first 1mL and keep the next 4mL. The antibody is always diluted by 2x after leaving the column. 5. When FITC coupling an antibody, you can determine the FITC to Protein ratio
) appropriate only if 1mL of conjugated-Ig is added to the column. If 2mL of conjugated-Ig is added, discard first 1mL and keep the next 4mL. The antibody is always diluted by 2x after leaving the column. 5. When FITC coupling an antibody
Generation of Antibody Molecules Through Antibody Engineering
been overcome to a large extent using genetic-engineering techniques to produce chimeric mouse/human and completely human antibodies. Such an approach is particularly suitable because of the domain structure of the antibody molecule ( 2 ), where functional
技术资料暂无技术资料 索取技术资料










